Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01518 NC HEALTHCARE
RT Nominal up0.830 +0.020 (+2.469%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others96,457-29.770%137,345161,967198,898217,552
Land & other Lease Assets143,662-6.836%154,203223,969308,785311,584
Intangible Assets243,771-2.495%250,008412,989424,330692,901
Interests in Asso. & JCEs12,190-3.514%12,6341,8092,57512,985
Other Non-current Assets4,82536.030%3,5478,73111,20812,492

500,905-10.190%557,737809,465945,7961,247,514
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories22,261-10.545%24,88521,14219,58415,687
Trade Receivables51,31652.563%33,63639,35128,57730,829
Cash & Bank Balances304,31034.603%226,079223,843299,211349,125
Other Current Assets65,60111.100%59,047177,095177,877233,513
Assets Held for Sale0--0000

443,48829.053%343,647461,431525,249629,154
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables40,8912.741%39,80027,44825,61826,353
S-T Debt & Leases56,97058.655%35,90836,74339,83939,753
Other Current Liabilities238,116-7.744%258,104226,986214,049228,356
Liab asso w/ Assets Held for Sale0--0000

335,9770.649%333,812291,177279,506294,462
Net Current Assets107,511993.147%9,835170,254245,743334,692
Total Assets Less Current Liabilities608,4167.196%567,572979,7191,191,5391,582,206
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases149,103-17.672%181,108243,498321,256316,648
Other Non-current Liabilities7,554-69.920%25,11351,98358,43132,030

156,657-24.034%206,221295,481379,687348,678
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital3350.000%335335335335
  Reserves521,94919.186%437,929737,124838,2981,210,470
  Others0--0000
Shareholders' Funds522,28419.171%438,264737,459838,6331,210,805
Non-controlling Interests(70,525)-8.305%(76,913)(53,221)(26,781)22,723
Others0--0000

451,75925.019%361,351684,238811,8521,233,528
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments----3826735,2013,326
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 19/07/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB 84,164,000
%Change--
EPS / (LPS)RMB 0.170
NBV Per Share (¥)RMB 1.066
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.